Medtech Accelerator Sofinnova MD Start III Launches a Call for Early Stage Medical Device Projects
8.6.2021 19:00:00 EEST | Business Wire | Press release
Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, announced today that its medtech accelerator, Sofinnova MD Start III, is launching a call for early-stage projects. Sofinnova MD Start III is part of the Sofinnova platform of funds and actively works with clinicians and entrepreneurs to develop disruptive therapeutic medical devices. This call for projects aims to award funding and mentorship to selected projects through the MDS III accelerator program. Proposals will be accepted until July 9th, 2021 via the online application form.
The Sofinnova MD Start III Fund recently raised over €50 million from key institutional and corporate investors and is managed by a dedicated team of serial entrepreneurs and clinicians. The fund’s goal is to transform innovative ideas into medical realities by creating and building world-class medical device companies dedicated to the development of novel therapeutic medical devices and procedures. To date, the fund has created 10 companies and reviewed over 2000 projects.
Sofinnova MD Start III has privileged access to breakthrough technologies in healthcare through its network of scientists and experts from the top research and development centers around the world. This call for proposals aims to build on the fund’s existing deal flow to enable greater access to funding and support to promising early-stage projects or companies with a strong clinical impact and a high potential to improve patient lives.
Selected projects will receive financial contribution through a maturation grant or an investment from the Sofinnova MD Start III Fund, as well as operational support, in line with the model of the accelerator as a hands-on, joint project development with inventors.
Anne Osdoit, Partner at Sofinnova Partners and a key member of the Sofinnova MD Start III Fund team, said “We are looking for the most promising cutting edge therapeutic projects in the medical device sector. With our strong operational, financial and strategic expertise as well as our vast industry network, we are able to provide the key components to successfully build companies that will advance patient care and medtech innovation.”
The review and selection process will be conducted by the Sofinnova MD Start III team, which consists of medical, scientific and engineering professionals, with extensive experience in medtech entrepreneurship and a strong network of stakeholders across the industry, corporate partners, and investors.
Sofinnova MD Start III builds on the success of MD Start I and MD Start II in creating and accelerating companies that offer revolutionary solutions for unmet medical needs, bridging the gap between patient care and medical device innovation.
###
About Sofinnova Partners
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future.
Founded in 1972, Sofinnova Partners is a deeply-established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners has over €2 billion under management. For more information, please visit: www.sofinnovapartners.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210608005876/en/
Contact information
Media:
Bommy Lee
Head of Communications, Sofinnova Partners
blee@sofinnovapartners.com
+33 (0) 6 47 71 38 11
North America
RooneyPartners LLC
Kate Barrette
kbarrette@rooneyco.com
+1 212 223 0561
France
StrategiesImage
Anne Rein
anne.rein@strategiesimage.com
+33 (0) 6 03 35 92 05
Italy
Havas PR Milan
Rafaella Casula
rafaella.casula@havaspr.com
+39 (0) 345 3780834
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
a2z Radiology AI Receives EU MDR Certification for AI That Detects 182 Findings Across Head, Chest, Abdomen and Pelvis CT12.11.2026 10:00:00 EET | Press release
a2z Radiology AI Inc. today announced that a2z-Drafter has been certified under the EU Medical Device Regulation (MDR). The software supports triage, detection and report drafting on CT scans of the head, chest, abdomen and/or pelvis. “Radiology teams have had to piece together separate AI tools for each condition and body region,” said Samir Rajpurkar, co-founder and CEO of a2z Radiology AI. “a2z-Drafter is one product that works on head, chest and abdomen-pelvis CT scans and gives the radiologist a structured starting point for the report. This certification lets us bring that to radiology teams in the European Union.” a2z-Drafter detects 182 validated radiological findings on CT studies of the head, chest, abdomen and/or pelvis, with supplementary attributes for selected findings. The findings span acute conditions such as subarachnoid hemorrhage, midline shift, pneumothorax and bowel obstruction, findings that need prompt workup such as obstructing ureteral stones and aortic aneury
KiddeFenwal Secures A2P System Certification from Centre National de Prévention et de Protection in France12.11.2026 10:00:00 EET | Press release
KiddeFenwal, the global leader in fire protection and safety controls, has received an Assurance Prévention Protection (A2P) System Certification for its NATURA™ inert gas fire suppression system. The designation from France’s Centre National de Prévention et de Protection (CNPP), one of the most respected fire safety testing and certification organizations in Europe, illustrates how KiddeFenwal is expanding the reach of its industry-leading technologies throughout the world with the support of independent, third-party evaluators. “KiddeFenwal is grateful to CNPP for standing behind our proven NATURA™ system,” said Rekha Agrawal, CEO of KiddeFenwal. “The certification enables our systems to protect the facilities and institutions that matter most, such as data centers, battery energy storage systems and power generation applications. This will lead to stronger protections all throughout France.” Since its launch in 2019, KiddeFenwal’s NATURA™ has offered facilities an enhanced means of
Shahrukhz Residences by Danube: Exclusive Gauri Khan-Designed Penthouses Worth USD 5.35 Million Each Sell Out on Launch Day12.11.2026 09:30:00 EET | Press release
Danube Properties unveiled Shahrukhz Residences by Danube, its fully furnished waterfront development in Dubai Maritime City, at a grand launch event on November 11 at Coca-Cola Arena, Dubai, in presence of the Danube Group Founder and Chairman Rizwan Sajan, Shah Rukh Khan and Gauri Khan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261111982153/en/ Shahrukhz Residences by Danube: Exclusive Gauri Khan-Designed Penthouses Worth USD 5.35 Million Each Sell Out on Launch Day (Photo: AETOSWire) Hosted by filmmaker Karan Johar, the event marked the second collaboration between Rizwan Sajan and SRK. A highlight of the evening was the announcement that all Gauri Khan-designed penthouses, each valued at USD 5.35 Million, had sold out on launch day. Expressing gratitude for the phenomenal response, Rizwan Sajan said, “Shahrukhz Residences is more than a development; it represents our ambition to create homes that bring together exce
Allianz Delivers Record Nine-month Result of 14.1 Billion Euros and Raises 2026 Outlook12.11.2026 08:06:00 EET | Press release
3Q 2026 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261111915059/en/ Oliver Bäte, Chief Executive Officer of Allianz SE Total business volume at 44.4 billion euros, an internal growth of 3.0 percent1. Excellent contribution from Asset Management and good internal growth in Property-Casualty. Operating profit rises 6.2 percent to 4.7 billion euros, driven by an outstanding result from the Asset Management segment, attributable to higher business volume and margins, and a strong contribution from Life/Health. Shareholders’ core net income increases 1.2 percent to 2.9 billion euros. Adjusted for offsetting measures following the sale of the stake in our Indian JVs, underlying growth is 3 percent. 9M 2026 Total business volume at 143.0 billion euros, an internal growth of 3.8 percent 1 , driven by excellent growth in Asset Management and good internal growth in Property-Casualty. Operating profit rises 7.8 percent to 14.1 bil
LTM Brings AI-Powered Quantum Error Mitigation to IBM Quantum Functions Catalog12.11.2026 07:30:00 EET | Press release
LTM, the Business Creativity partner to the world’s largest enterprises, today announced that AI-QEM, its proprietary AI-powered Quantum Error Mitigation capability, is now available in the IBM Quantum Functions Catalog. With this milestone, LTM becomes the first Global Systems Integrator (GSI) worldwide to publish a function in the catalog. The IBM Quantum Functions Catalog is an ecosystem of partner-built quantum software services that simplify quantum workflows and enable researchers and enterprises to run quantum experiments more efficiently for algorithm development and application prototyping. AI-QEM is available as a circuit function, allowing users of eligible IBM Quantum access plans to apply LTM's error mitigation capability directly within their Qiskit workflows. Quantum computers are inherently susceptible to noise and errors that can impact computational outcomes. While conventional error mitigation techniques often require additional circuit executions, quantum processing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom